<blockquote
from="official Columbia/CPTech announcement"
edits="some non-standard characters replaced"
why-go="Paid agents of the Englobulators will attend. So should we.">
---------- Forwarded message ----------
Date: Wed, 26 Nov 2003 13:21:32 -0500
From: James Love <james.love@cptech.org>
To: random-bits@lists.essential.org
Subject: [Random-bits] Dec 4 Columbia/CPTech R&D event
This is the most recent version of the agenda for a
December 4 event at Columbia University on Access to
Medicines and the Financing of Innovations in Health Care.
The web page for the event at Columbia (which should be
updated later today) is here:
http://www.earthinstitute.columbia.e...al_R_and_D.pdf
Workshop on
Access to Medicines and the Financing of Innovations in
Health Care
Hosted by
The Program on Science, Technology, and Global Development
The Earth Institute at Columbia University
and the
The Consumer Project on Technology
Washington, DC
December 4, 2003
Lerner Hall (room 569), Columbia University
Can we promote "access to medicines for all," and finance
faster, more appropriate innovation in health care?
Paragraph 4 of the Doha Declaration on Health, calls upon
member countries to implement patent laws in a manner
supportive of public health, and in particular "to promote
access to medicines for all." The financing of medical R&D
now relies heavily on the enforcement of intellectual
property rights. A growing body of evidence suggests that
ever-higher levels of IPR protection may distort the
research agenda and slow the pace of follow-on inventions,
as well as limit access to existing inventions. This
workshop examines these tensions, and considers alternative
approaches to financing the development of new medical
inventions.
To register for the event:
Joy Spencer, CPTech
Phone 1.202.387.8030
joy.spencer@cptech.org
Will Masters, Columbia University
Phone 1.212.854.7633
wmasters@ei.columbia.edu
Access to Medicines and the Financing of Innovations in
Health Care
December 4, 2003
Agenda (as of November 26)
8:45-9:00 Welcome and introductions
Jeffrey Sachs, Director, the Earth Institute, Columbia
University
9:00-10:00 Proposals to Address Market Failures in R&D - I
Richard Nelson, George Blumenthal Professor of International
and Public Affairs, Business and Law, Columbia University
(Moderator)
James Love, Director, CPTech - New Global Framework for
Funding R&D (20 minutes)
Tim Hubbard, Head of Human Genome Analysis, Wellcome
Trust/Sanger Institute, Four Alternatives to the Price
System: (1) A Prize System, (2) Public Institutions to
Develop New Drugs, (3) Open Collaborative Development Models
for Public Goods, and (4) Competitive Intermediators
Discussion
10:00-10:15 Coffee Break
10:15-11:15 Proposals to Address Market Failures in R&D -
II
Will Masters, Center on Globalization and Sustainable
Development, Columbia University, (Moderator)
Henry Grabowski, Director of the Program in Pharmaceuticals
and Health Economics, Duke University - New subsidies for
neglected diseases
Jerome Reichman, Bunyan S. Womble Professor of Law, Duke
University, and Tracy Lewis, Fuqua School of Business, Duke
University. Reform of Intellectual Property Rules: The
Replacement of Exclusive Rights with Liability rules for the
Protection of Investment in R&D
11:15-12:30 Reactions and discussion
Sakiko Fukuda-Parr, Director & Editor in Chief of Human
Development Report, UNDP (moderator)
Spring Gombe, Health Action International
Bruce Lehman, President and CEO, International Intellectual
Property Institute
Brandon Lerch, Legislative Assistant, Office of Congressman
Gutknecht
Discussion
12:30-1:30 Lunch break
1:30-2:30 Costs of patent protection and benefits of
innovation
Juan Rovira, Senior Health Economist, World Bank (Moderator)
Frank Lichtenberg, Professor, Columbia Business School.
The economic benefits of medical innovation
Andrew W. K. Farlow - The Department of Economics, Oriel
College, Oxford University. Costs of monopoly pricing under
patent protection
Shubham Chaudhuri, Department of Economics, Columbia -
Welfare effects of TRIPS in India
2:30-3:30 R&D as a Global Good
James Orbinski, Centre for International Health, University
of Toronto (Moderator)
Robert Weissman - Co-Director, Essential Action. R&D in
international treaties
Nicoletta Dentico, Medecins Sans Frontieres (MSF), Lessons
from the Tobacco Control and Landmine Conventions
Amy Kapczynski, Yale University - Best practices for
management of publicly funded R&D
Discussion
3:30-4:00 Coffee Break and showing of video clip from
"Dying for Drugs"
4:00 - 5:00 Open discussion: Priority-setting for
analysis and advocacy
Richard Nelson, Columbia University
James Love, Consumer Project on Technology
5:00-5:30 Wrap-Up: Where do we go from here?
Jeffrey Sachs, Columbia University
--
James Love, Director, Consumer Project on Technology
http://www.cptech.org, mailto:james.love@cptech.org
tel. +1.202.387.8030, mobile +1.202.361.3040
_______________________________________________
Random-bits mailing list
Random-bits@lists.essential.org
http://lists.essential.org/mailman/listinfo/random-bits
</blockquote>
Distributed poC TINC:
Jay Sulzberger <secretary@lxny.org>
Corresponding Secretary LXNY
LXNY is New York's Free Computing Organization.
